Filed under Articles Tagged with 1-testosterone , 14c , Anabolic Agents , Anabolic Effects , Androgenic , Androgenic Effects , Androgens , Androst , Androstenediol , Androstenedione , Blood Volume , Body Composition , Clin Endocrinol Metab , Dehydroepiandrosterone , Dhea , Dhea Converts , Double Bond , Erratum , Estrogenic Effects , Exercise Endurance , Hair Loss , Hiv Patients , Immune System , J Biol Chem , J Clin Endocrinol Metab , Khorram , Lardy , Lean Mass , Life Extension , Midlife Women , Muscle Mass , Nbs , Nitrogen Retention , Oxo , Primary Metabolite , Primary Metabolites , Proc Natl Acad Sci , Proc Natl Acad Sci Usa , Rabkin , Rsquo , Sleeplessness , Target , Thermogenic , Vivo Conversion , Wellbeing , Youthful Energy
The most serious complication of anabolic steroid use is the development of hepatic tumors, either adenoma or hepatocellular carcinoma. The hepatic tumors arise in patients on long term androgenic steroids, usually during therapy of aplastic anemia or hypogonadism, but occasionally in athletes or body builders using anabolic steroids illicitly. Tumors are typically found after 5 to 15 years of use, but onset within 2 years of starting therapy with testerosterone esters has been described. Many of the case reports have occurred in patients with other risk factors for cancer, such as Fanconi?s syndrome, iron overload or chronic hepatitis C (from blood transfusions). However, hepatic adenomas and hepatocellular carcinoma have also been described in patients taking androgenic steroids who have no other evidence of liver disease and normal histology in the nontumor parts of the liver. The pathology of the tumors is usually hepatic adenoma or ?well differentiated? hepatocellular carcinoma or hepatic adenoma with areas of malignant transformation. Rare instances of cholangiocarcinoma and angiosarcoma have also been described in patients on long term androgenic steroids. Clinical presentation is generally with right upper quadrant discomfort and a hepatic mass found clinically or on imaging studies. Routine liver tests are often normal unless there is extensive spread or rupture or an accompanying liver disease. Alphafetoprotein levels are usually normal. There is often (but not always) spontaneous regression in the tumor when the anabolic steroids are stopped. Hepatocellular carcinoma arising during anabolic steroid therapy is believed to have a better prognosis than that related to cirrhosis or chronic hepatitis B and C; however, deaths from hepatic rupture or tumor spread and metastasis have been reported in patients with anabolic steroid related hepatocellular carcinoma without cirrhosis.
Currently using the Galenika pharma test 250 (1ml amps)
This test great!
Two amps weekly spaced apart 1 on Monday and again on Thursday.
By the end of week 1 I noticed small pumps in the gym and morning wood was starting.
End of week 2 I was feeling great! Oily skin, estro starting to rise. So I added my anti e at tis point because I felt the itchy nips starting to happen
Week 4 my muscles were really filling up. Pumps were in full swing in the gym. I was up about 8 pounds and continued to climb.
The test is nice and clear with minimal pip.
I noticed with running 500 mgs weekly of this test that seemed to sweat ALOT more than my other experiences running 500 of ugl. I usually don't run over 500 mgs weekly because I'll add another compound if I get bored and want more juice in my system.
The test felt strong and I plan on using the rest for a cruise as I feel it's accurately dosed.
The other products are about to be started and will post a review once used.